fda compounding semaglutide crackdown 2025 news How Crackdowns Are Affecting GLP-1 Use In FDA steps up crackdown on

Several medications for postprandial hyperglycemia, such asGI, glinide, DPP4 inhibitors, and GLP-1 analogs, have been commercially available for the past decade and have been shown to exert efficient antihyperglycemic effects and additional protective effects against CVDs [9,10,24]

Rare adverse events may not yet be fully characterized

Weight loss doesnt happen overnight even if youre taking a GLP-1 weight-loss medication like Wegovy

Who injections are better for: People who want evidence-based, FDA-approved therapy Those eligible for insurance reimbursement Patients with diabetes or cardiovascular risks Anyone prioritizing consistent, measurable results Who patches may appeal to: People afraid of needles Curious biohackers who want to try supplements rather than true GLP-1s Those willing to experiment with their health Expert Opinion C